Addressing the Medical Need in CLL: How BTK Inhibitors Are Improving Outcomes

Get up to date on optimal use of BTK inhibitors in the care of your patients with CLL with an interactive on-demand Webcast and downloadable slides from a live Webinar along with expert commentaries and our BTK Inhibitor AE Management Tool.

Share

Program Content

Activities

BTK Inhibitors in CLL
My Perspective on 3 Questions I Am Asked on BTK Inhibitors for CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 16, 2020

Expires: November 15, 2021

BTKi in CLL: FAQ
Expert Answers to Frequently Asked Questions on BTK Inhibitors for Treatment of CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 15, 2021

Expires: January 14, 2022

Activities

Overview: BTK Inhibitors in CLL
Overview of the BCR Pathway and Use of BTK Inhibitors in CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

Selecting First-line Therapy in CLL
Addressing the Medical Need in CLL: Selecting First-line Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

BTK Inhibition in R/R CLL
BTK Inhibitors for Relapsed/Refractory Chronic Lymphocytic Leukemia
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

<i>EP</i>: BTK Inhibitors in CLL
ExpressPoints: Addressing the Medical Need in CLL: How BTK Inhibitors Are Improving Outcomes
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2020

Expires: December 08, 2021

No activities added yet

Faculty

cover img faculity

Ian Flinn, MD, PhD

Chief Scientific Officer
OneOncology
Nashville, Tennessee

cover img faculity

Susan M. O Brien, MD

Professor of Medicine
Department of Leukemia
University of Texas M.D. Anderson Cancer Center
Houston, Texas

cover img faculity

John Pagel, MD, PhD

Associate Professor
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.